Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: William Strop who wrote (994)	3/10/1999 9:53:00 PM
From: Scott H. Davis	Read Replies (1) \| Respond to of 1972

Really makes no sense, contrast broad market advances over the last two years, the consistant, multifront clinical progress, major pharma endorsements, and VICL is lower than a year and 2 years ago. Very frustrating. But the risk/reward picture continues to improve behind the scene qtr by qtr. Scott

To: William Strop who wrote (994)	3/10/1999 10:55:00 PM
From: Jim Roof	Read Replies (1) \| Respond to of 1972

I am right there with you. VICL appears to have gotten the attention of enough traders who are content to buy 10-11 and sell 15-18 for a long time. I think the sell-off into the 7's may have been the first major exit of frustrated investors. Perhaps there will be another... perhaps this is it right now. At any rate, with all the fundamental advances and new partnerships it makes no sense for VICL to be stuck here. This is one that I will play from my gut. I am staying put. Jim